Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
NPJ Breast Cancer|April 13, 2026
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancerMarion T Van Mackelenbergh, Nicole Pfarr, Karsten Weber, et al.
Nature Medicine|July 9, 2025
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detectionGabriele Campanella, Neeraj Kumar, Swaraj Nanda, et al.
The Journal of Molecular Diagnostics : JMD|March 25, 2020
Evaluation of a Hybrid Capture-Based Pan-Cancer Panel for Analysis of Treatment Stratifying Oncogenic Aberrations and ProcessesLeonie I Kroeze, Richarda M de Voer, Eveline J Kamping, et al.
Cell Reports|May 31, 2023
Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancerMassimo Saini, Laura Schmidleitner, Helena Domínguez Moreno, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trialsSonia L Villegas, Valentina Nekljudova, Nicole Pfarr, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
Neuroendocrinology|May 20, 2026
Clinical impact of molecular tumor board inclusion on treatment outcomes in neuroendocrine neoplasmsMaryam Barsch, Linda Gräßel, Patrick Metzger, et al.
Science Immunology|November 5, 2021
XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cellsAdam Wahida, Madeleine Müller, Andreas Hiergeist, et al.
Cancer Cell|June 23, 2023
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targetsJoscha Griger, Sebastian A Widholz, Moritz Jesinghaus, et al.
Pageof 12